Streetbeat News

Earnings

HSDT

Helius Medical Tech (NASDAQ:HSDT) is set to release its latest quarterly earnings report on November 9, 2023. Analysts estimate an earnings per share (EPS) of $-6.00. The company's past performance shows a trend of beating EPS estimates but experiencing a drop in share price. The stock is currently trading at $7.23, down 44.5% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 6:01 pm

LVO

LiveOne (NASDAQ:LVO) is set to release its quarterly earnings report on November 9, 2023. Analysts estimate an EPS of $0.00. The company's past performance shows a pattern of share price changes following earnings reports. The stock is currently trading at $1.12 and has seen an 80.07% increase over the last 52 weeks.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 6:01 pm

DARE

Dare Bioscience (NASDAQ:DARE) is set to release its latest quarterly earnings report on November 9, 2023. Analysts estimate an earnings per share (EPS) of $-0.10. The company's past performance shows a mixed trend of EPS estimates and actuals, with the last quarter showing no difference between the two. The share price increased by 6.0% the day after the last earnings release. However, the stock has been down 61.06% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 6:01 pm

BFRI

Biofrontera (NASDAQ:BFRI) is set to release its latest quarterly earnings report on November 9, 2023. Analysts estimate an earnings per share (EPS) of $-4.26. The company's past performance shows a trend of missing EPS estimates, which has often led to a drop in share price. The company's shares are currently trading at $4.2 and have seen a 78.74% decrease over the last 52-week period.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 6:01 pm

AMEH

Apollo Medical Holdings reported better-than-expected Q3 earnings per share (EPS), leading to a rise in its stock price.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 6:01 pm

HOOK

HOOKIPA Pharma (NASDAQ:HOOK) is set to release its latest quarterly earnings report on November 9, 2023. Analysts estimate an earnings per share (EPS) of $-0.21. The company's past performance shows a pattern of share price changes following earnings reports. The company's shares are currently trading at $0.4534 and have seen a 62.54% decrease over the last 52-week period.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 6:01 pm

XTNT

Xtant Medical Hldgs (AMEX:XTNT) is set to release its latest quarterly earnings report on November 9, 2023. Analysts estimate an earnings per share (EPS) of $0.00. The company's past performance shows a mixed trend of EPS estimates and actuals, with the share price fluctuating accordingly. The stock is currently trading at $1.18 and has seen a 77.59% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 6:01 pm

TMC

TMC Metals is set to release its latest quarterly earnings report on November 9, 2023. Analysts estimate an earnings per share (EPS) of $-0.10. The company's past performance shows a pattern of beating EPS estimates, which has often resulted in an increase in share price. The company's shares are currently trading at $1.04 and have seen a 15.48% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 6:01 pm

JRVR

James River Gr Hldgs (NASDAQ:JRVR) reported Q3 earnings of $0.48 per share, beating the analyst consensus estimate of $0.47 by 2.13%. However, the company's quarterly sales of $202.63 million missed the analyst consensus estimate of $226.47 million by 10.53%.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 6:00 pm

KNDI

Kandi Technologies Group Inc reported a Q3 FY23 sales increase of 8.2% Y/Y to $36.4 million. Gross margin expanded to 30.0% from 18.9% the prior year. Operating expenses rose to $14.5 million from $8.6 million in the same period of 2022. Net income was $1.3 million, an improvement compared to $1.1 million during the same period in 2022. The company's CEO stated that their primary focus for 2024 is to increase their market share in the North American market.

Portfolio Pulse from Lekha Gupta

November 08, 2023 | 5:57 pm